The likely 1997 mixed-sex reference used modified [Nle27]GHRH(1–29)-NH2 at 10 mcg/kg SC nightly for 16 weeks after four placebo weeks in 19 adults aged 55–71. Sleep quality was unchanged. A separate study in 11 older men used GHRH(1–29) 2 mg SC nightly for six weeks. Neither validates ordinary sermorelin 200–300 mcg community cycles.
Context: October 15 2026 article audit; primary evidence and author claims distinguished.
Limitations: Related-analogue evidence is explicitly identified; it must not be assigned directly to ordinary sermorelin or interpreted as comparative potency evidence.
Distinct protocol, timing or sequence preserved from the saved research material. Unreported fields remain unknown.
Context: Attributed research context; population or formulation not fully specified.
Attributed proposal / anecdote: Amount: 200–300 mcg; Frequency: Once nightly; Duration: 12 weeks, then 4–6 weeks off; Timing: Bedtime; fasted morning also mentioned; Route: Not documented
Limitations: Author-reported community schedule, not a validated treatment regimen or personal recommendation. Cycling, rotation and adjunct superiority are not established. Missing fields are not inferred.